Well Told Grants

Grants / Department of Health and Human Services / National Institutes of Health

RFA-AA-22-003: Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed)

Closed Closed September 30, 2022 Opportunity RFA-AA-22-003

This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.

National Institutes of Health offered grants of up to $350,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on September 30, 2022.

From the official notice on Grants.gov, last changed July 21, 2022. Checked November 7, 2026.

About this NIH notice

Projects funded under RFA-AA-22-003 were run by National Institute on Alcohol Abuse and Alcoholism (NIAAA, 8 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.

Application due dates, page limits and budget limits are set in the notice. Read RFA-AA-22-003 in the NIH Guide.

Key dates

PostedJuly 21, 2022
DeadlineSeptember 30, 2022
Archived by Grants.govNovember 5, 2022

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

All 15 applicant types the notice lists

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

What the grant funds

The goal of this FOA is to support collaborative research projects conducted by multidisciplinary teams on early liver transplantation for ALD patients. The research objectives of these observational clinical studies concern factors that influence the selection, management, and outcomes of ELT. Recruited into these longitudinal studies would be adult ALD patients being considered for ELT. Patients would be followed for sufficient time to determine long-term outcomes related to ELT.

Category: Health.

Funded under RFA-AA-22-003 so far

NIH funded 8 projects under RFA-AA-22-003 in fiscal 2023 to 2026, at 8 institutions. The median yearly award was $401,460.

Recently funded projects
ProjectInstitutionFiscal yearAward
2/4-The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease R01Columbia University Health Sciences2026$434,417
4/4: The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopsychosocial Outcomes of Early Liver Transplant for Alcohol-Associated Liver Disease R01Henry Ford Health + Michigan State University Health Sciences2026$375,468
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) R01Methodist Hospital Research Institute2026$403,739
1/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease R01UT Southwestern Medical Center2026$441,322
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) R01University of Pennsylvania2026$392,416
3/4-The INTEGRATE Study: Evaluating INTEGRATEd Care to Improve Biopsychosocial Outcomes of Early Liver Transplantation for Alcohol-Associated Liver Disease R01University of Miami School of Medicine2026$400,730
3/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) R01University of Wisconsin-Madison2026$388,655
1/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE) R01University of Southern California2026$577,500

From NIH RePORTER, which lists each project once per fiscal year it was funded. Amounts are the yearly award.

Who has won Alcohol Research Programs grants before

From fiscal 2021 to 2025, Alcohol Research Programs (93.273) awarded $2.2 billion across 2,255 grant awards, an average of $974,579 per award.

Largest recipients, fiscal 2021 to 2025
RecipientStateAwardsAmount
Yale UnivConnecticut75$86.5 million
University of North Carolina at Chapel HillNorth Carolina76$60.7 million
Trustees of Indiana UniversityIndiana47$54.8 million
University of California, San DiegoCalifornia47$54.5 million
The Medical University of South CarolinaSouth Carolina57$45.8 million

Top states: California ($342 million), New York ($184 million), North Carolina ($144 million), Massachusetts ($120 million), Connecticut ($98.3 million).

Applying now

This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.

Questions people ask

Is RFA-AA-22-003 still open?

No. It closed on September 30, 2022.

Who can apply for Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

What is the deadline for Early Liver Transplantation Cohort Study for Alcohol-associated Liver Diseases (Collaborative R01 Clinical Trial Not Allowed)?

Closed September 30, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

How much funding is available?

Awards of up to $350,000 each.

Who has been funded under RFA-AA-22-003?

NIH RePORTER lists 8 projects funded under RFA-AA-22-003 in fiscal 2023 to 2026, at 8 institutions. The most were at Columbia University Health Sciences, Henry Ford Health + Michigan State University Health Sciences, Methodist Hospital Research Institute.

Who has won Alcohol Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, University of North Carolina at Chapel Hill, Trustees of Indiana University. The program made 2,255 awards worth $2.2 billion in that time.

Similar open grants